Xencor (XNCR) Change in Acquisitions & Divestments (2015 - 2026)
Xencor's (XNCR) quarterly Change in Acquisitions & Divestments came in at $100.0 million in Q1 2026, down 15.98% year-on-year from $119.0 million in Q1 2025, and up 14.9% on a QoQ basis from $87.0 million in Q4 2025.
Xencor (XNCR) Change in Acquisitions & Divestments (2015 - 2026) Analysis & Trends
Xencor (XNCR) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $100.0 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 15.98% year-over-year to $100.0 million in Q1 2026; TTM through Mar 2026 was $386.1 million, a 44.77% decrease from a year earlier, with the FY2025 full-year figure at $405.1 million, down 31.35% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $100.0 million, up from $87.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for XNCR reached as high as $471.7 million in Q3 2024 and fell as low as -$339.6 million in Q3 2023.
- Historically, Change in Acquisitions & Divestments has averaged $73.0 million across 5 years, with a median of $87.0 million in 2025.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 1093.55% in 2025 and fell as far as 1741.72% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at -$205.3 million in 2022, then plunged by 65.41% to -$339.6 million in 2023, then soared by 133.61% to $114.1 million in 2024, then declined by 23.78% to $87.0 million in 2025, then climbed by 14.9% to $100.0 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $100.0 million in Q1 2026, $87.0 million in Q4 2025, and $304.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.97 Mn |
| Mar 31, 2026 | 99.97 Mn |
| Dec 31, 2025 | 87.00 Mn |
| Dec 31, 2025 | 87.00 Mn |
| Sep 30, 2025 | 304.69 Mn |
| Sep 30, 2025 | 304.69 Mn |
| Jun 30, 2025 | -105.59 Mn |
| Jun 30, 2025 | -105.59 Mn |
| Mar 31, 2025 | 118.99 Mn |
| Mar 31, 2025 | 118.99 Mn |
| Dec 31, 2024 | 114.14 Mn |
| Dec 31, 2024 | 114.14 Mn |
| Sep 30, 2024 | 471.67 Mn |
| Sep 30, 2024 | 471.67 Mn |
| Jun 30, 2024 | -5.73 Mn |
| Jun 30, 2024 | -5.73 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Sep 30, 2023 | -339.58 Mn |
| Sep 30, 2023 | -339.58 Mn |